Name:
Dr Charles Kennedy PhD FBPhS
Organisation:
University of Strathclyde
Year elected:
2013
Primary professional setting:
Academia
Charles obtained a BSc (Honours) in Pharmacology from Aberdeen University then a PhD from University College London, where he worked with Professor Geoffrey Burnstock, FRS on the division of P2 receptors into the P2X and P2Y subtypes. Following a postdoctoral position at Michigan State University, he was a Beit Research Memorial Fellow at Cambridge University, working with Graeme Henderson, before joining Strathclyde University, where he is a Reader.His research focuses on the pharmacological properties and physiological and pathophysiological functions of P2X and P2Y receptors, with particular reference at present to the pulmonary circulation and to P2Y heteromultimer formation. Charles is currently an editor of the BJP, Purinergic Signalling, and Autonomic Neuroscience: Basic & Clinical. He chairs the IUPHAR P2X receptor nomenclature sub-committee and sits on the P2Y receptor sub-committee. He represents the department on CHOPT and has acted as an undergraduate degree external examiner at a number of universities.